340B · December 16, 2025 · Drug Channels Institute, an HMP Global company
340B Hit $81 Billion in 2024: Why CMS and the IRA Are Poised to Cool the Program’s Runaway Growth (VIDEO)
Yesterday, I published 340B Hit $81 Billion in 2024 (+23%): Why CMS and the IRA Are Poised to Cool the Program’s Runaway Growth.
Yesterday, I published 340B Hit $81 Billion in 2024 (+23%): Why CMS and the IRA Are Poised to Cool the Program’s Runaway Growth.
For those who prefer watching to reading, I asked AI to turn our latest 340B analysis into a tidy little video.
Let me know what you think of this format and whether you'd like to see more.
Click here if you can't see the video below.
For those who prefer watching to reading, I asked AI to turn our latest 340B analysis into a tidy little video.
Let me know what you think of this format and whether you'd like to see more.
Click here if you can't see the video below.
340B · Gross-to-Net Bubble · Hospitals · Inflation Reduction Act of 2022 · Medicare Part D · Specialty Drugs